Curia New York, Inc., a subsidiary of Curia Global, Inc., has received authorization to carry out production activities in its location in Rensselaer, New York, which is classified as Subzone 121A of the Foreign-Trade Zone. This authorization follows a notification submitted on August 8, 2024, and a public comment period that was announced in the Federal Register. On December 6, 2024, the FTZ Board decided no further review was needed, allowing Curia New York to proceed with their activities according to the regulations of the FTZ Board.
Simple Explanation
Curia New York got the green light to make special ingredients for medicine at their place in New York called Subzone 121A. After checking with the public and making sure everything was okay, they don't need any more approvals to start their work there.